Cargando…
Attribution of NKG2DL to the inhibition of early stage allogeneic tumors in mice
Allogeneic tumors are eventually rejected by adaptive immune responses, however, little is known about how allogeneic tumors are eradicated at the early stage of tumor development. In present study, we found that NKG2DL low expressing cancer cells were developed into palpable allogeneic tumors in mi...
Autores principales: | Hua, Li, Fang, Mingli, Dong, Boqi, Guo, Sheng, Cui, Cuiyun, Liu, Jiwei, Yao, Yun, Xiao, Yue, Li, Xin, Ren, Yunjia, Meng, Xiuping, Hao, Xu, Zhao, Peiyan, Song, Yilan, Wang, Liying, Yu, Yongli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347697/ https://www.ncbi.nlm.nih.gov/pubmed/27448968 http://dx.doi.org/10.18632/oncotarget.10693 |
Ejemplares similares
-
Rae1 drives NKG2D binding‐dependent tumor development in mice by activating mTOR and STAT3 pathways in tumor cells
por: Zhao, Peiyan, et al.
Publicado: (2020) -
Correlation of Surface Toll-Like Receptor 9 Expression with IL-17 Production in Neutrophils during Septic Peritonitis in Mice Induced by E. coli
por: Ren, Yunjia, et al.
Publicado: (2016) -
New prospects on the NKG2D/NKG2DL system for oncology
por: Ullrich, Evelyn, et al.
Publicado: (2013) -
Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy
por: Ding, Hui, et al.
Publicado: (2018) -
c-Myc Targets HDAC3 to Suppress NKG2DL Expression and Innate Immune Response in N-Type SCLC through Histone Deacetylation
por: Zhao, Peiyan, et al.
Publicado: (2022)